» Articles » PMID: 16983177

Primary "empty Sella" in Adults: Endocrine Findings

Overview
Journal Endocr J
Specialty Endocrinology
Date 2006 Sep 20
PMID 16983177
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence of impaired pituitary function in many subjects with primary empty sella (PES) has been reported. We conducted a retrospective analysis of our patients with PES, in order to ascertain presenting symptoms and endocrine status on diagnosis and during follow-up. Magnetic resonance imaging (MRI) of the pituitary leading to the diagnosis of PES was performed in 8 patients (5 F and 3 M, age: 60.1 +/- 3.3 years, M +/- SE; group 1) after the diagnosis of global anterior hypopituitarism (H), and in 20 patients (F, age 56.9 +/- 2.2 years, group 2) for other clinical reasons. Baseline determinations of pituitary and target gland hormones and of IGF-I were performed. GH response to GHRH plus arginine stimulation was also evaluated. Ten age- and BMI-matched subjects (7 F, 3 M, age: 53.0 +/- 4.0 years) with normal pituitary function served as controls (C). In group 1, the presenting symptoms leading to the diagnosis of H were consciousness disturbances, hyponatremia and chronic fatigue. The GH response to stimulation was absent (peak:1.0 +/- 0.3 ng/ml) and IGF-I levels (60.1 +/- 9.3 ng/ml) were significantly lower (p<0.001) than in C and group 2 PES patients. Among group 2 PES patients, the main presenting symptoms were headache and visual alterations. Baseline hormone levels proved normal in 17 subjects, while slight hyperprolactinemia was observed in 2 and hypogonadotropic hypogonadism in one. The GH response to stimulation (12.9 +/- 3.4 ng/ml) and IGF-I levels (141.7 +/- 12.0 ng/ml) were lower (p<0.05) than in C (GH: 33.4 +/- 8.8 ng/ml, IGF-I: 193.1 +/- 20.3 ng/ml). PES is a heterogeneous condition that ranges from hypopituitarism to various degrees of isolated GH deficiency, and which needs careful endocrine assessment, treatment and follow-up.

Citing Articles

Empty sella syndrome: an update.

Padovano Sorrentino F, Chiloiro S, Giampietro A, Bianchi A, Pontecorvi A, De Marinis L Pituitary. 2024; 28(1):13.

PMID: 39738761 DOI: 10.1007/s11102-024-01475-z.


Management of a Growth Hormone-Secreting Pituitary Macroadenoma Associated With Idiopathic Intracranial Hypertension and an Empty Sella.

King H, Luther E, Morell A, Ivan M, Komotar R Cureus. 2023; 15(1):e34471.

PMID: 36874650 PMC: 9982051. DOI: 10.7759/cureus.34471.


The Link Between Empty Sella Syndrome, Fibromyalgia, and Chronic Fatigue Syndrome: The Role of Increased Cerebrospinal Fluid Pressure.

Hulens M, Dankaerts W, Rasschaert R, Bruyninckx F, De Mulder P, Bervoets C J Pain Res. 2023; 16:205-219.

PMID: 36721849 PMC: 9884441. DOI: 10.2147/JPR.S394321.


EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY.

Bestepe N, Aydin C, Tam A, Ercan K, Ersoy R, Cakir B Acta Endocrinol (Buchar). 2022; 18(1):97-101.

PMID: 35975262 PMC: 9365410. DOI: 10.4183/aeb.2022.97.


Acromegaly with empty sella syndrome.

Daya R, Seedat F, Purbhoo K, Bulbulia S, Bayat Z Endocrinol Diabetes Metab Case Rep. 2021; 2021.

PMID: 34253687 PMC: 8284961. DOI: 10.1530/EDM-21-0049.